Quality-of-life impact of non-neoplastic voice disorders: A meta-analysis

Annals of Otology, Rhinology and Laryngology

Volumn 115, Issue 2, 2006, Pages 128-134

  Cohen, Seth M ^a   Dupont, William D ^a   Courey, Mark S ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Laryngeal disease; Meta analysis; Quality of life; Voice disorder

Indexed keywords

ANALYSIS OF VARIANCE; ARTICLE; ATROPHY; CHRONIC DISEASE; CYST; DYSPHONIA; HUMAN; INFLAMMATION; KRUSKAL WALLIS TEST; LARYNX DISORDER; LARYNX EDEMA; LARYNX INJURY; LARYNX PAPILLOMATOSIS; MEDLINE; META ANALYSIS; NEUROLOGIC DISEASE; PAPILLOMA; PARKINSON DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SHORT FORM 36; TREATMENT OUTCOME; VOCAL CORD PARALYSIS; VOICE HANDICAP INDEX;

EID: 33644529079     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940611500209     Document Type: Article

References (39)

1. Behrman A, Sulica L, He T. Factors predicting patient perception of dysphonia caused by benign vocal fold lesions. Laryngoscope 2004;114:1693-700.
2. Rosen CA, Lee AS, Osborne J, Zullo T, Murry T. Development and validation of the Voice Handicap Index-10. Laryngoscope 2004;114:1549-56.
3. Hogikyan ND, Sethuraman G. Validation of an instrument to measure voice-related quality of life (V-RQOL). J Voice 1999;13:557-69.
4. Benninger MS, Ahuja AS, Gardner G, Grywalski C. Assessing outcomes for dysphonia patients. J Voice 1998;12:540-50.
5. Bowling A, Bond M, Jenkinson C, Lamping DL. Short Form 36 (SF-36) Health Survey questionnaire: which normative data should be used? Comparisons between the norms provided by the Omnibus Survey in Britain, the Health Survey for England and the Oxford Health Life Survey. J Public Health Med 1999;21:255-70.
6. Ware JE Jr, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey: manual and interpretation guide. Boston, Mass: The Health Institute, New England Medical Center, 1993.
7. Rothman KJ, Greenland S. Modern epidemiology. 2nd ed. Philadelphia, Pa: Lippincott-Raven, 1998:660-1.
8. Rosen CA, Murry T. Voice Handicap Index in singers. J Voice 2000;14:370-7.
9. Spector BC, Netterville JL, Billante C, Clary J, Reinisch L, Smith TL. Quality-of-life assessment in patients with unilateral vocal cord paralysis. Otolaryngol Head Neck Surg 2001;125:176-82.
10. Benninger MS, Gardner G, Grywalski C. Outcomes of botulinum toxin treatment for patients with spasmodic dysphonia. Arch Otolaryngol Head Neck Surg 2001;127:1083-5.
11. Courey MS, Garrett CG, Billante CR, et al. Outcomes assessment following treatment of spasmodic dysphonia with botulinum toxin. Ann Otol Rhinol Laryngol 2000;109:819-22.
12. Rosen CA, Thekdi AA. Vocal fold augmentation with injectable calcium hydroxylapatite: short-term results. J Voice 2004;18:387-91.
13. Pearl AD, Woo P, Ostrowski R, Mojica J, Mandell DL, Costantino P. A preliminary report on micronized AlloDerm injection laryngoplasty. Laryngoscope 2002;112:990-6.
14. Gliklich RE, Glovsky RM, Montgomery WW. Validation of a voice outcome survey for unilateral vocal cord paralysis. Otolaryngol Head Neck Surg 1999;120:153-8.
15. Johns MM, Garrett CG, Hwang J, Ossoff RH, Courey MS. Quality-of-life outcomes following laryngeal endoscopic surgery for non-neoplastic vocal fold lesions. Ann Otol Rhinol Laryngol 2004;113:597-601.
16. Jacobson BH, Johnson A, Grywalski C, Silbergleit A, Jacobson G, Benninger MS. The voice handicap index (VHI): development and validation. Am J Speech Lang Pathol 1997;6:66-70.
17. Klein S, Piccirillo JF, Painter C. Comparative contrast of voice measurements. Otolaryngol Head Neck Surg 2000;123:164-9.
18. Carrau RL, Khidr A, Crawley JA, Hillson EM, Davis JK, Pashos CL. The impact of laryngopharyngeal reflux on patient-reported quality of life. Laryngoscope 2004;114:670-4.
19. Behrman A, Shikowitz MJ, Dailey S. The effect of upper airway surgery on voice. Otolaryngol Head Neck Surg 2002;127:36-42.
20. Hsiung MW, Lu P, Kang BH, Wang HW. Measurement and validation of the voice handicap index in voice-disordered patients in Taiwan. J Laryngol Otol 2003;117:478-81.
21. Ma EPM, Yiu EML. Voice activity and participation profile: assessing the impact of voice disorders on daily activities. J Speech Lang Hear Res 2001;44:511-24.
22. Speyer R, Wieneke GH, Dejonckere PH. Self-assessment of voice therapy for chronic dysphonia. Clin Otolaryngol Allied Sci 2004;29:66-74.
23. Wilson JA, Webb A, Carding PN, Steen IN, MacKenzie K, Deary U. The Voice Symptom Scale (VoiSS) and the Vocal Handicap Index (VHI): a comparison of structure and content. Clin Otolaryngol Allied Sci 2004;29:169-74.
24. Blumin JH, Pcolinsky DE, Atkins JP. Laryngeal findings in advanced Parkinson's disease. Ann Otol Rhinol Laryngol 2004;113:253-8.
25. Behrman A, Abramson AL, Myssiorek D. A comparison of radiation-induced and presbylaryngeal dysphonia. Otolaryngol Head Neck Surg 2001;125:193-200.
26. de Jong FI, Cornells BE, Wuyts FL, et al. A psychological cascade model for persisting voice problems in teachers. Folia Phoniatr Logop 2003;55:91-101.
27. MacKenzie K, Millar A, Wilson JA, Sellars C, Deary IJ. Is voice therapy an effective treatment for dysphonia? A randomised controlled trial. BMJ 2001;323:658-61.
28. Timmermans B, De Bodt MS, Wuyts FL, et al. Poor voice quality in future elite vocal performers and professional voice users. J Voice 2002;16:372-82.
29. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice 2002;16:274-7.
30. Lee L, Daughton S, Scheer S, et al. Use of acupuncture for the treatment of adductor spasmodic dysphonia: a preliminary investigation. J Voice 2003;17:411-24.
31. Guimaraes I, Abberton E. An investigation of the Voice Handicap Index with speakers of Portuguese: preliminary data. J Voice 2004;18:71-82.
32. Wilson JA, Deary IJ, Millar A, MacKenzie K. The quality of life impact of dysphonia. Clin Otolaryngol Allied Sci 2002;27:179-82.
33. Pribuisiene R, Uloza V, Saferis V. Multidimensional voice analysis of reflux laryngitis patients. Eur Arch Otorhinolaryngol 2005;262:35-40.
34. Roy N, Weinrich B, Gray SD, et al. Voice amplification versus vocal hygiene instruction for teachers with voice disorders: a treatment outcomes study. J Speech Lang Hear Res 2002;45:625-38.
35. Roy N, Gray SD, Simon M, Dove H, Corbin-Lewis K, Stemple JC. An evaluation of the effects of two treatment approaches for teachers with voice disorders: a prospective randomized clinical trial. J Speech Lang Hear Res 2001;44:286-96.
36. Roy N, Weinrich B, Gray SD, Tanner K, Stemple JC, Sapienza CM. Three treatments for teachers with voice disorders: a randomized clinical trial. J Speech Lang Hear Res 2003;46:670-88.
37. Powitzky ES, Khaitan L, Garrett CG, Richards WO, Courey M. Symptoms, quality of life, videolaryngoscopy, and twenty-four-hour triple-probe pH monitoring in patients with typical and extraesophageal reflux. Ann Otol Rhinol Laryngol 2003;112:859-65.
38. Hill DS, Akhtar S, Corroll A, Croft CB. Quality of life issues in recurrent respiratory papillomatosis. Clin Otolaryngol Allied Sci 2000;25:153-60.
39. Gliklich RE, Metson R. The health impact of chronic sinusitis in patients seeking otolaryngologic care. Otolaryngol Head Neck Surg 1995;113:104-9.